Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report) shot up 5.5% during trading on Wednesday . The stock traded as high as $5.36 and last traded at $5.35. 165,486 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 341,812 shares. The stock had previously closed at $5.07.
Analyst Ratings Changes
Separately, LADENBURG THALM/SH SH lowered shares of Bionano Genomics from a “buy” rating to a “neutral” rating in a research report on Friday, November 15th.
Check Out Our Latest Stock Report on Bionano Genomics
Bionano Genomics Stock Up 11.9 %
Hedge Funds Weigh In On Bionano Genomics
A number of large investors have recently bought and sold shares of BNGO. Carret Asset Management LLC increased its position in shares of Bionano Genomics by 89.0% in the third quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock worth $39,000 after acquiring an additional 40,055 shares in the last quarter. GSA Capital Partners LLP purchased a new position in shares of Bionano Genomics in the third quarter valued at $46,000. Finally, Geode Capital Management LLC boosted its position in Bionano Genomics by 47.3% in the 3rd quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock valued at $401,000 after buying an additional 283,639 shares during the last quarter. Hedge funds and other institutional investors own 11.35% of the company’s stock.
About Bionano Genomics
Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.
See Also
- Five stocks we like better than Bionano Genomics
- Election Stocks: How Elections Affect the Stock Market
- 3 Turnaround Stocks in the Early Innings With More Upside to Come
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Whirlpool: Buy This High-Yielding Value Before It Spins Higher
- Investing in Construction Stocks
- Commvault Systems: Share Price Primed to Vault Higher in 2025
Receive News & Ratings for Bionano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.